Pages that link to "Q28335385"

The following pages link to Adverse side effects of methylphenidate among mentally retarded children with ADHD (Q28335385):

Displaying 25 items.

• Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I. (Q30449130) (← links)
• Pharmacologic management of psychiatric and behavioral symptoms in mental retardation. (Q33837484) (← links)
• The stimulants revisited. (Q34005063) (← links)
• Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit (Q34402618) (← links)
• Methylphenidate treatment (Q34626119) (← links)
• Overcoming barriers to effective early parenting interventions for attention-deficit hyperactivity disorder (ADHD): parent and practitioner views. (Q34822926) (← links)
• Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities (Q35107986) (← links)
• The use of psychostimulants in pervasive developmental disorders (Q36218479) (← links)
• Stimulant medication treatment of target behaviors in children with autism: a population-based study (Q36978496) (← links)
• A rational approach to the child with mental retardation for the paediatrician (Q37481950) (← links)
• Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation (Q39706175) (← links)
• NIMH Collaborative Multisite Multimodal Treatment Study of Children with ADHD: I. Background and Rationale (Q40476916) (← links)
• Psychopharmacology in Children with Developmental Disabilities (Q40486882) (← links)
• Pharmacotherapy of disorders of adolescents. (Q40815133) (← links)
• Risks and benefits of drugs used in the management of the hyperactive child (Q40832393) (← links)
• Safety Issues in the Use of Methylphenidate An American Perspective (Q41598962) (← links)
• The international consensus process on psychopharmacology and intellectual disability (Q41682508) (← links)
• Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder (Q50312401) (← links)
• Treatment of children with Williams syndrome with methylphenidate (Q51102902) (← links)
• The management of ADHD and associated problems in a young person with cleidocranial dysostosis (CCD) and mild intellectual disability. (Q51910574) (← links)
• A playroom observation procedure to assess children with mental retardation and ADHD. (Q51992084) (← links)
• Classroom behavior and children with mental retardation: comparison of children with and without ADHD. (Q52025853) (← links)
• Recent advances in paediatric psychopharmacology: A brief overview (Q60727690) (← links)
• Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities (Q93205804) (← links)
• Le TDAH chez les enfants et les adolescents, partie 3 : l’évaluation et le traitement en cas d’association au trouble du spectre de l’autisme, au handicap intellectuel ou à la prématurité (Q94142923) (← links)